Suwa Maternity Clinic to Close Infertility Treatment Outpatient Services in March Next Year… Previously Announced Japan’s First Surrogacy Case and Performed Fetal Reduction Surgery – Yomiuri Shimbun

News Highlights

Suwa Maternity Clinic, based in Suwa City, Nagano Prefecture, has decided to close its infertility treatment outpatient services as of March 2027. The clinic was the first in Japan to publicly announce a case of surrogacy and has provided advanced reproductive medical services such as fetal reduction surgery. This closure raises concerns about its impact on regional healthcare. The closure can be seen as a symbolic event reflecting challenges faced by many medical institutions, including issues with successor physicians and the need to review management strategies.

M&A Medical Editorial Department’s Perspective

The closure of Suwa Maternity Clinic’s infertility treatment outpatient services signifies more than just the end of a single facility. The clinic’s history of challenging innovative endeavors, such as publicly announcing Japan’s first surrogacy case and providing advanced reproductive medicine like fetal reduction surgery, is noteworthy in the history of infertility treatment in Japan. However, even with such advanced initiatives, the fact that the clinic faced structural challenges like the absence of a successor and reached the difficult decision to close its outpatient services is significant. In particular, it underscores the importance for medical institutions facing a lack of successors to consider third-party succession (M&A) as an option, beyond just closing or ceasing operations. From the perspective of maintaining regional healthcare, this case highlights the necessity of early business succession planning and collaboration with experts well-versed in medical M&A.

Points Raised by This News

• The closure of a clinic with a track record of advanced reproductive medicine, including the announcement of Japan’s first surrogacy case, suggests the difficulty in succeeding highly specialized medical practices.
• A reduction in infertility treatment options within a region can directly impact patients’ Quality of Life (QOL).
• With the aging of directors and clinic presidents, it is urgent to consider third-party succession (M&A) when the absence of a successor becomes apparent.
• Business succession for medical institutions is not merely a transfer of management rights but also importantly involves the inheritance of long-cultivated medical techniques and know-how.

Practical Questions Arising from This News

• If a successor cannot be found, what kind of third-party succession (M&A) schemes can be considered as alternatives to closing or ceasing operations?
• How should existing patients be handled following the closure of the infertility treatment outpatient services? Will referrals to other medical institutions be made?
• What impact will the closure of Suwa Maternity Clinic have on the infertility treatment medical provision system in Nagano Prefecture and surrounding areas?

If You Feel “Should I Consult Too?”

Is your clinic also facing a situation where the director or president is aging, and no successor is in sight? Before giving up and thinking “closure is the only option,” please consult with experts in medical M&A. Even advanced medical institutions like Suwa Maternity Clinic face succession challenges. By exploring the possibility of third-party succession (M&A) early on, you can continue to contribute to regional healthcare, maintain staff employment, and broaden your options for your second life.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics with a success fee-only basis, as an M&A support institution certified by the Small and Medium Enterprise Agency. Consultations are accepted with strict confidentiality. Free consultation here